中心性浆液性脉络膜视网膜病变的治疗新进展  

Recent advances in the treatment of central serous chorioretinopathy

作　　者：何桂琴 李和平 廖丹 许立帅(综述)[1] 杨小丽(审校)[1] HE Guiqin;LI Heping;LIAO Dan;XU Lishuai;YANG Xiaoli(From the Department of Ophthalmology,the Affiliated Hospital of North Sichuan Medical College,Nanchong 637000,Sichuan Province,China)

机构地区：[1]川北医学院附属医院眼科,四川南充637000

出　　处：《西南医科大学学报》2020年第5期538-542,共5页Journal of Southwest Medical University

基　　金：四川省教育厅重点项目(17ZA0171)。

摘　　要：中心性浆液性脉络膜视网膜病变(central serous chorioretinopathy,CSC)是继年龄相关性黄斑病变、糖尿病视网膜病变、视网膜分支静脉阻塞后的第四大常见的非手术性视网膜疾病。视网膜下液的持续存在可能引起视网膜神经上皮层与视网膜色素上皮层(retinal pigment epithelium,RPE)结构永久性紊乱。但目前尚无统一的治疗方案。本文就其治疗方法的研究进展进行综述。Central serous chorioretinopathy(CSC)is the fourth most common non-surgical retinal disease after age-related maculopathy,diabetic retinopathy,and branch retinal vein occlusion.Persistent subretinal fluid may cause permanent structural disorder of the retinal neuroepithelial layer and the retinal pigment epithelium.However,no unified treatment regimen is available.This article is a review of the research advances in treatment methods of the disease.

关 键 词：中心性浆液性脉络膜视网膜病变 消除病因治疗 药物治疗 光动力疗法 经瞳孔温热治疗 阈下微脉冲激光 

分 类 号：R774.5[医药卫生—眼科]